Welcome to LookChem.com Sign In|Join Free
  • or
5H-[1,3]Dioxolo[4,5-f]indole-6,7-dione, commonly known as etoposide, is a semi-synthetic derivative of podophyllotoxin, originally extracted from the roots of the Mayapple plant. It is a potent chemotherapeutic agent characterized by its ability to inhibit the enzyme topoisomerase II, which plays a crucial role in DNA replication and cell division. Etoposide's mechanism of action involves disrupting these processes, leading to the induction of cell death in cancer cells. Despite its effectiveness, it also has the potential to cause DNA damage in healthy cells, which may result in side effects such as bone marrow suppression, nausea, and hair loss. Etoposide is typically administered intravenously in a clinical setting under the supervision of a healthcare professional.

107583-34-6

Post Buying Request

107583-34-6 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

107583-34-6 Usage

Uses

Used in Oncology:
5H-[1,3]Dioxolo[4,5-f]indole-6,7-dione is used as a chemotherapeutic agent for the treatment of various types of cancer, including lung cancer, testicular cancer, and lymphomas. It is particularly effective due to its ability to inhibit topoisomerase II, a key enzyme in DNA replication and cell division, thereby inducing cell death in cancer cells.
Used in Cancer Research:
In addition to its clinical applications, 5H-[1,3]Dioxolo[4,5-f]indole-6,7-dione is also utilized in cancer research to study the mechanisms of cell death and the role of topoisomerase II in DNA replication and cell division. This research helps in the development of new therapeutic strategies and the understanding of the molecular basis of cancer.
Used in Drug Development:
5H-[1,3]Dioxolo[4,5-f]indole-6,7-dione serves as a starting point for the development of new anticancer drugs. Its unique mechanism of action and potent activity against various cancer types make it an attractive candidate for the design and synthesis of novel compounds with improved efficacy and reduced side effects.
Used in Drug Formulation:
In the pharmaceutical industry, 5H-[1,3]Dioxolo[4,5-f]indole-6,7-dione is used in the formulation of various cancer treatment regimens. It is often combined with other chemotherapeutic agents to enhance the overall therapeutic effect and overcome drug resistance in cancer cells.
Used in Drug Delivery Systems:
To improve the bioavailability and therapeutic outcomes of 5H-[1,3]Dioxolo[4,5-f]indole-6,7-dione, various drug delivery systems have been developed. These systems, including liposomes, nanoparticles, and polymeric carriers, aim to enhance the drug's delivery to cancer cells, reduce side effects, and improve patient compliance.

Check Digit Verification of cas no

The CAS Registry Mumber 107583-34-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,7,5,8 and 3 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 107583-34:
(8*1)+(7*0)+(6*7)+(5*5)+(4*8)+(3*3)+(2*3)+(1*4)=126
126 % 10 = 6
So 107583-34-6 is a valid CAS Registry Number.

107583-34-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 5H-[1,3]Dioxolo[4,5-f]indole-6,7-dione

1.2 Other means of identification

Product number -
Other names 5H-1,3-Dioxolo[4,5-f]indole-6,7-dione

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:107583-34-6 SDS

107583-34-6Relevant academic research and scientific papers

Insights into structure-activity relationships of 3-arylhydrazonoindolin-2-one derivatives for their multitarget activity on β-amyloid aggregation and neurotoxicity

Purgatorio, Rosa,De Candia, Modesto,De Palma, Annalisa,De Santis, Francesco,Pisani, Leonardo,Campagna, Francesco,Cellamare, Saverio,Altomare, Cosimo Damiano,Catto, Marco

, (2018/07/13)

Despite the controversial outcomes of clinical trials executed so far, the prevention of β-amyloid (Aβ) deposition and neurotoxicity by small molecule inhibitors of Aβ aggregation remains a target intensively pursued in the search of effective drugs for treating Alzheimer’s disease (AD) and related neurodegeneration syndromes. As a continuation of previous studies, a series of new 3-(2-arylhydrazono)indolin-2-one derivatives was synthesized and assayed, investigating the effects of substitutions on both the indole core and arylhydrazone moiety. Compared with the reference compound 1, we disclosed equipotent derivatives bearing alkyl substituents at the indole nitrogen, and fairly tolerated bioisosteric replacements at the arylhydrazone moiety. For most of the investigated compounds, the inhibition of Aβ40 aggregation (expressed as pIC50) was found to be correlated with lipophilicity, as assessed by a reversed-phase HPLC method, through a bilinear relationship. The N1-cyclopropyl derivative 28 was tested in cell-based assays of Aβ42 oligomer toxicity and oxidative stress induced by hydrogen peroxide, showing significant cytoprotective effects. This study confirmed the versatility of isatin in preparing multitarget small molecules affecting different biochemical pathways involved in AD.

A palladium-catalyzed synthesis of isatins (1H-Indole-2,3-diones) from 1-(2-haloethynyl)-2-nitrobenzenes

S?derberg, Bj?rn C.G.,Gorugantula, Sobha P.,Howerton, Chet R.,Petersen, Jeffrey L.,Dantale, Shubhada W.

experimental part, p. 7357 - 7363 (2009/12/04)

An inherently regiospecific synthesis of isatins (1H-indole-2,3-diones) starting from 1-halo-2-nitrobenzenes is described. The isatins are formed by an intramolecular palladium-catalyzed annulation of 2-(2-haloethynyl)-1-nitrobenzenes via the formation of 2-haloisatogens.

Synthesis of substituted quinoline-4-carboxylic acids

Lackey,Sternbach

, p. 993 - 997 (2007/10/02)

A high yielding synthesis of a variety of quinoline-4-carboxylic acids has been accomplished using a modified Pfitzinger approach involving the condensation of a ketone with an isatin derivative employing aqueous acid conditions. A convenient synthesis of

Biological activities and quantitative structure-activity relationships of spiro[imidazolidine-4,4'(1'H)-quinazoline]-2,2',5(3'H)-triones as aldose reductase inhibitors

Yamagishi,Yamada,Ozaki,Asao,Shimizu,Suzuki,Matsumoto,Matsuoka,Matsumoto

, p. 2085 - 2094 (2007/10/02)

A series of spiro[imidazolidine-4,4'(1'H)-quinazoline]-2,2',5(3'H)-triones were prepared and tested for aldose reductase inhibitory activity. The 6'- halogenated derivatives were found to be highly potent in vitro inhibitors of male rabbit lens aldose reductase and in vivo inhibitors of polyol accumulation in the sciatic nerves of galactosemic rats. Of these, (4R)-6'- chloro-3'-methylspiro[imidazolidine-4,4'(1'H)-quinazoline]-2,2',5(3'H)-trione (67) showed the most potent in vitro and in vivo activities. An oral dose of 3 g/kg of compound 67 caused neither death nor behavioral abnormality in the preliminary acute toxicity study using mice and rats. Compound 67 was selected as a candidate for further evaluation. The quantitative structure- activity relationships in this series are also discussed.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 107583-34-6